Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
about
Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.MUC16 (CA125): tumor biomarker to cancer therapy, a work in progressCA125 in ovarian cancerSuccessful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.Immunotherapy for ovarian cancer.Immunotherapy for gynaecological malignancies.Tumor markers in ovarian carcinoma.Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imagingImmunotherapy opportunities in ovarian cancer.Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.Synthesis and pre-clinical evaluation of an (18)F-labeled single-chain antibody fragment for PET imaging of epithelial ovarian cancerClinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.Monoclonal antibodies therapies for ovarian cancer.Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administrationEngineering therapeutic monoclonal antibodies.
P2860
Q30444706-2F34EFF9-9014-4BAB-B5DD-90ED20781B4FQ33311571-A9411D75-7178-407E-8D88-D881F72FBBECQ33713506-7FAEBE39-71CC-40A4-A701-33A73F3C6E54Q33859857-9A4FC701-FE87-44B3-B505-6AADFC62DC06Q34007762-78EF046A-EBE7-481B-8737-60BD1B2590D1Q35164189-9CF804EE-007D-4862-9DE6-23B4B9646B26Q36239661-3AC92B0E-C746-4C22-8ABF-9569A32A924AQ36767181-B67C1CFD-4625-4FA3-8168-584F793AD850Q36944360-6D3A7851-47F0-4678-B825-332CBB837986Q37086013-238F7336-DB56-43EC-9147-E66F0D82119EQ37122878-F7F5FFD7-61D0-4C39-BBA8-307FFC1DF3BFQ37136748-0B8BFFCA-2141-4B0F-8341-23C9C53A0BF5Q37326840-44DE0F65-CB39-424D-ADBF-8D5E6EC6997BQ38078400-D244FB4F-3F8E-4F3B-8435-5D991EE97D39Q42287395-8F48B474-EC35-40C7-B6A0-A3CA244F6BD0Q47820029-88179344-1F5C-437B-98D1-EE075C5F2524
P2860
Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
@ast
Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
@en
type
label
Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
@ast
Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
@en
prefLabel
Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
@ast
Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
@en
P2860
P1476
Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
@en
P2093
Jonathan S Berek
P2860
P304
P356
10.1517/14712598.4.7.1159
P407
P577
2004-07-01T00:00:00Z